Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway

PLoS ONE

Volumn 12, Issue 6, 2017, Pages

  Yan, Hui ^a   Ajuwon, Kolapo M ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BUTYRIC ACID; CLAUDIN 3; CLAUDIN 4; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PROTEIN KINASE B; TIGHT JUNCTION PROTEIN; ADENYLATE KINASE; CYTOKINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME REGULATION; INTESTINAL BARRIER FUNCTION; INTESTINE EPITHELIUM CELL; INTESTINE FUNCTION; LIMIT OF QUANTITATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN RNA BINDING; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL LINE; DOSE RESPONSE; DRUG EFFECTS; INTESTINE MUCOSA; METABOLISM; PERMEABILITY; PHOSPHORYLATION; PIG; TIGHT JUNCTION;

ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; ANIMALS; BUTYRIC ACID; CELL LINE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; INTESTINAL MUCOSA; PERMEABILITY; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SWINE; TIGHT JUNCTION PROTEINS; TIGHT JUNCTIONS; UP-REGULATION;

EID: 85021355430     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0179586     Document Type: Article

References (61)

1. Brandtzaeg P. The gut as communicator between environment and host: immunological consequences. Eur J Pharmacol. 2011; 668 Suppl 1:S16-32. Epub 2011/08/06. https://doi.org/10.1016/j. ejphar.2011.07.006 PMID: 21816150.
2. Neunlist M, Van Landeghem L, Mahe MM, Derkinderen P, des Varannes SB, Rolli-Derkinderen M. The digestive neuronal-glial-epithelial unit: a new actor in gut health and disease. Nat Rev Gastroenterol Hepatol. 2013; 10(2):90-100. https://doi.org/10.1038/nrgastro.2012.221 PMID: 23165236
3. Vellenga L, Egberts HJ, Wensing T, van Dijk JE, Mouwen JM, Breukink HJ. Intestinal permeability in pigs during rotavirus infection. Am J Vet Res. 1992; 53(7):1180-3. Epub 1992/07/01. PMID: 1497189.
4. Peace RM, Campbell J, Polo J, Crenshaw J, Russell L, Moeser A. Spray-dried porcine plasma influences intestinal barrier function, inflammation, and diarrhea in weaned pigs. J Nutr. 2011; 141(7):1312-7. Epub 2011/05/27. https://doi.org/10.3945/jn.110.136796 PMID: 21613450.
5. Hu CH, Gu LY, Luan ZS, Song J, Zhu K. Effects of montmorillonite-zinc oxide hybrid on performance, diarrhea, intestinal permeability and morphology of weanling pigs. Animal Feed Science and Technology. 2012; 177(1-2):108-15. https://doi.org/10.1016/j.anifeedsci.2012.07.028
6. Pinton P, Nougayrede JP, Del Rio JC, Moreno C, Marin DE, Ferrier L, et al. The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression. Toxicol Appl Pharmacol. 2009; 237(1):41-8. Epub 2009/03/18. https://doi.org/10.1016/j.taap.2009.03.003 PMID: 19289138.
7. Pearce SC, Mani V, Boddicker RL, Johnson JS, Weber TE, Ross JW, et al. Heat stress reduces intestinal barrier integrity and favors intestinal glucose transport in growing pigs. PLoS ONE. 2013; 8(8): e70215. Epub 2013/08/13. https://doi.org/10.1371/journal.pone.0070215 PMID: 23936392; PubMed Central PMCID: PMC3731365.
8. Awad WA, Aschenbach JR, Khayal B, Hess C, Hess M. Intestinal epithelial responses to Salmonella enterica serovar Enteritidis: effects on intestinal permeability and ion transport. Poult Sci. 2012; 91 (11):2949-57. Epub 2012/10/24. https://doi.org/10.3382/ps.2012-02448 PMID: 23091155.
9. Quinteiro-Filho WM, Ribeiro A, Ferraz-de-Paula V, Pinheiro ML, Sakai M, Sa LR, et al. Heat stress impairs performance parameters, induces intestinal injury, and decreases macrophage activity in broiler chickens. Poult Sci. 2010; 89(9):1905-14. Epub 2010/08/17. https://doi.org/10.3382/ps.2010-00812 PMID: 20709975.
10. Murugesan GR, Ledoux DR, Naehrer K, Berthiller F, Applegate TJ, Grenier B, et al. Prevalence and effects of mycotoxins on poultry health and performance, and recent development in mycotoxin counteracting strategies. Poult Sci. 2015; 94(6):1298-315. Epub 2015/04/05. https://doi.org/10.3382/ps/pev075 PMID: 25840963.
11. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009; 9 (11):799-809. Epub 2009/10/27. https://doi.org/10.1038/nri2653 PMID: 19855405.
12. Clayburgh DR, Shen L, Turner JR. A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest. 2004; 84(3):282-91. Epub 2004/02/10.https://doi.org/10.1038/labinvest.3700050 PMID: 14767487.
13. Vaarala O. Leaking gut in type 1 diabetes. Curr Opin Gastroenterol. 2008; 24(6):701-6. Epub 2009/01/06. https://doi.org/10.1097/MOG.0b013e32830e6d98 PMID: 19122519.
14. Weber P, Brune T, Ganser G, Zimmer K. Gastrointestinal symptoms and permeability in patients with juvenile idiopathic arthritis. Clinical and experimental rheumatology. 2002; 21(5):657-62.
15. Ashida H, Ogawa M, Kim M, Mimuro H, Sasakawa C. Bacteria and host interactions in the gut epithelial barrier. Nat Chem Biol. 2012; 8(1):36-45. Epub 2011/12/17. https://doi.org/10.1038/nchembio.741 PMID: 22173358.
16. Hammer AM, Morris NL, Earley ZM, Choudhry MA. The First Line of Defense: The Effects of Alcohol on Post-Burn Intestinal Barrier, Immune Cells, and Microbiome. Alcohol Res. 2015; 37(2):209-22. Epub 2015/12/24. PMID: 26695746; PubMed Central PMCID: PMC4590618.
17. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell. 1996; 84(3):345-57. Epub 1996/02/09. https://doi.org/https://doi.org/10.1016/S0092-8674(00)81279-9 PMID: 8608588.
18. Yan H, Potu R, Lu H, Vezzoni de Almeida V, Stewart T, Ragland D, et al. Dietary fat content and fiber type modulate hind gut microbial community and metabolic markers in the pig. PLoS ONE. 2013; 8(4): e59581. Epub 2013/04/11. https://doi.org/10.1371/journal.pone.0059581 PMID: 23573202; PubMed Central PMCID: PMC3616062.
19. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009; 58(8):1091-103. https://doi.org/10.1136/gut.2008.165886 PMID: 19240062
20. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, et al. Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet-Induced Obesity and Diabetes in Mice. Diabetes. 2008; 57(6):1470-81. https://doi.org/10.2337/db07-1403 PMID: 18305141
21. Guilloteau P, Martin L, Eeckhaut V, Ducatelle R, Zabielski R, Van Immerseel F. From the gut to the peripheral tissues: the multiple effects of butyrate. Nutrition research reviews. 2010; 23(02):366-84.
22. Raqib R, Sarker P, Bergman P, Ara G, Lindh M, Sack DA, et al. Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc Natl Acad Sci U S A. 2006; 103 (24):9178-83. Epub 2006/06/03. https://doi.org/10.1073/pnas.0602888103 PMID: 16740661; PubMed Central PMCID: PMC1482586.
23. Nakanishi N, Tashiro K, Kuhara S, Hayashi T, Sugimoto N, Tobe T. Regulation of virulence by butyrate sensing in enterohaemorrhagic Escherichia coli. Microbiology. 2009; 155(Pt 2):521-30. Epub 2009/02/10.https://doi.org/10.1099/mic.0.023499-0 PMID: 19202100.
24. Peng L, Li ZR, Green RS, Holzman IR, Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr. 2009; 139(9):1619-25. Epub 2009/07/25. https://doi.org/10.3945/jn.109.104638 PMID: 19625695; PubMed Central PMCID: PMC2728689.
25. Peng L, He Z, Chen W, Holzman IR, Lin J. Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr Res. 2007; 61(1):37-41. Epub 2007/01/11. https://doi.org/10.1203/01.pdr.0000250014.92242.f3 PMID: 17211138.
26. Brosnahan AJ, Brown DR. Porcine IPEC-J2 intestinal epithelial cells in microbiological investigations. Vet Microbiol. 2012; 156(3-4):229-37. Epub 2011/11/15. https://doi.org/10.1016/j.vetmic.2011.10.017 PMID: 22074860; PubMed Central PMCID: PMC3289732.
27. Arce C, Ramirez-Boo M, Lucena C, Garrido JJ. Innate immune activation of swine intestinal epithelial cell lines (IPEC-J2 and IPI-2I) in response to LPS from Salmonella typhimurium. Comp Immunol Microbiol Infect Dis. 2010; 33(2):161-74. Epub 2008/09/19. https://doi.org/10.1016/j.cimid.2008.08.003 PMID: 18799216.
28. Yang F, Wang A, Zeng X, Hou C, Liu H, Qiao S. Lactobacillus reuteri I5007 modulates tight junction protein expression in IPEC-J2 cells with LPS stimulation and in newborn piglets under normal conditions. BMC microbiology. 2015; 15(1):32. Epub 2015/04/19. https://doi.org/10.1186/s12866-015-0372-1 PMID: 25888437; PubMed Central PMCID: PMC4350629.
29. Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, Arditi M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. Journal of immunology (Baltimore, Md: 1950). 2001; 167(3):1609-16. Epub 2001/07/24. PMID: 11466383.
30. Schlegel N, Leweke R, Meir M, Germer CT, Waschke J. Role of NF-kappaB activation in LPS-induced endothelial barrier breakdown. Histochem Cell Biol. 2012; 138(4):627-41. Epub 2012/06/22. https://doi.org/10.1007/s00418-012-0983-7 PMID: 22718247.
31. Guo S, Nighot M, Al-Sadi R, Alhmoud T, Nighot P, Ma TY. Lipopolysaccharide Regulation of Intestinal Tight Junction Permeability Is Mediated by TLR4 Signal Transduction Pathway Activation of FAK and MyD88. J Immunol. 2015; 195(10):4999-5010. Epub 2015/10/16. https://doi.org/10.4049/jimmunol. 1402598 PMID: 26466961; PubMed Central PMCID: PMC4637237.
32. Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, Turner JR. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol. 2005; 166(2):409-19. Epub 2005/02/01. https://doi.org/https://doi.org/10.1016/S0002-9440(10)62264-X PMID: 15681825; PubMed Central PMCID: PMC1237049.
33. Al-Sadi R, Ye D, Dokladny K, Ma TY. Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability. J Immunol. 2008; 180(8):5653-61. Epub 2008/04/09. PMID: 18390750; PubMed Central PMCID: PMC3035485.
34. Marette A. Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings. Current opinion in clinical nutrition and metabolic care. 2002; 5(4):377-83. Epub 2002/07/11. PMID: 12107372.
35. Glass DJ. Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol. 2005; 37(10):1974-84. Epub 2005/08/10.https://doi.org/10.1016/j.biocel.2005.04.018 PMID: 16087388.
36. Tan B, Yin Y, Kong X, Li P, Li X, Gao H, et al. L-Arginine stimulates proliferation and prevents endotoxin-induced death of intestinal cells. Amino Acids. 2010; 38(4):1227-35. Epub 2009/08/12. https://doi.org/10.1007/s00726-009-0334-8 PMID: 19669080; PubMed Central PMCID: PMC2850530.
37. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29(9):e45. Epub 2001/05/09. https://doi.org/10.1093/nar/29.9.e45 PMID: 11328886; PubMed Central PMCID: PMC55695.
38. Sambuy Y, De Angelis I, Ranaldi G, Scarino ML, Stammati A, Zucco F. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol. 2005; 21(1):1-26. Epub 2005/05/04. https://doi.org/10.1007/s10565-005-0085-6 PMID: 15868485.
39. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature. 1998; 395(6699):284-8. Epub 1998/09/29. https://doi.org/10.1038/26239 PMID: 9751057.
40. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. Journal of immunology (Baltimore, Md: 1950). 1999; 162(7):3749-52. Epub 1999/04/14. PMID: 10201887.
41. Pinton P, Braicu C, Nougayrede JP, Laffitte J, Taranu I, Oswald IP. Deoxynivalenol impairs porcine intestinal barrier function and decreases the protein expression of claudin-4 through a mitogen-activated protein kinase-dependent mechanism. J Nutr. 2010; 140(11):1956-62. Epub 2010/09/24. https://doi.org/10.3945/jn.110.123919 PMID: 20861219.
42. Yan H, Ajuwon KM. Mechanism of Butyrate Stimulation of Triglyceride Storage and Adipokine Expression during Adipogenic Differentiation of Porcine Stromovascular Cells. PLoS ONE. 2015; 10(12): e0145940. Epub 2015/12/30. https://doi.org/10.1371/journal.pone.0145940 PMID: 26713737; PubMed Central PMCID: PMC4694642.
43. Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut. 2006; 55(10):1512-20. https://doi.org/10.1136/gut.2005.085373 PMID: 16966705
44. Oswald IP. Role of intestinal epithelial cells in the innate immune defence of the pig intestine. Vet Res. 2006; 37(3):359-68. https://doi.org/10.1051/vetres:2006006 PMID: 16611553
45. Vergauwen H. The IPEC-J2 Cell Line. In: Verhoeckx K, Cotter P, López-Expósito I, Kleiveland C, Lea T, Mackie A, et al., editors. The Impact of Food Bioactives on Health: in vitro and ex vivo models. Cham: Springer International Publishing; 2015. p. 125-34.
46. Ruemmele FM, Schwartz S, Seidman EG, Dionne S, Levy E, Lentze MJ. Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut. 2003; 52(1):94-100. https://doi.org/10.1136/Gut.52.1.94 PMID: 12477768
47. Mandal M, Olson DJ, Sharma T, Vadlamudi RK, Kumar R. Butyric acid induces apoptosis by up-regulating Bax expression via stimulation of the c-Jun N-terminal kinase/activation protein-1 pathway in human colon cancer cells. Gastroenterology. 2001; 120(1):71-8. Epub 2001/02/24. https://doi.org/https://doi.org/10.1053/gast.2001.20897 PMID: 11208715.
48. Forster C. Tight junctions and the modulation of barrier function in disease. Histochem Cell Biol. 2008; 130(1):55-70. Epub 2008/04/17. https://doi.org/10.1007/s00418-008-0424-9 PMID: 18415116; PubMed Central PMCID: PMC2413111.
49. Balda MS, Matter K. Tight junctions at a glance. Journal of Cell Science. 2008; 121(22):3677-82. https://doi.org/10.1242/jcs.023887 PMID: 18987354
50. Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol. 2009; 124(1):3-20; quiz 1-2. Epub 2009/06/30. https://doi.org/10.1016/j.jaci. 2009.05.038 PMID: 19560575; PubMed Central PMCID: PMC4266989.
51. Piche T, Barbara G, Aubert P, Bruley des Varannes S, Dainese R, Nano JL, et al. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut. 2009; 58(2):196-201. https://doi.org/10.1136/gut.2007.140806 PMID: 18824556
52. Guttman JA, Finlay BB. Tight junctions as targets of infectious agents. Biochimica et biophysica acta. 2009; 1788(4):832-41. Epub 2008/12/09. https://doi.org/10.1016/j.bbamem.2008.10.028 PMID: 19059200.
53. Ahdieh M, Vandenbos T, Youakim A. Lung epithelial barrier function and wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-gamma. American journal of physiology Cell physiology. 2001; 281(6):C2029-38. Epub 2001/11/08. PMID: 11698262.
54. Fusunyan RD, Quinn JJ, Ohno Y, MacDermott RP, Sanderson IR. Butyrate Enhances Interleukin (IL)-8 Secretion by Intestinal Epithelial Cells in Response to IL-1[beta] and Lipopolysaccharide1. Pediatr Res. 1998; 43(1):84-90. https://doi.org/10.1203/00006450-199804001-00501 PMID: 9432117
55. Wang H, Ji Y, Wu G, Sun K, Sun Y, Li W, et al. l-Tryptophan Activates Mammalian Target of Rapamycin and Enhances Expression of Tight Junction Proteins in Intestinal Porcine Epithelial Cells. J Nutr. 2015; 145(6):1156-62. Epub 2015/04/17. https://doi.org/10.3945/jn.114.209817 PMID: 25878205.
56. Hall MN. mTOR-what does it do? Transplant Proc. 2008; 40(10 Suppl):S5-8. Epub 2009/04/11. https://doi.org/10.1016/j.transproceed.2008.10.009 PMID: 19100909.
57. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell. 2007; 129(7):1261-74. Epub 2007/07/03. https://doi.org/10.1016/j.cell.2007.06.009 PMID: 17604717; PubMed Central PMCID: PMC2756685.
58. Hardie DG, Hawley SA, Scott JW. AMP-activated protein kinase-development of the energy sensor concept. J Physiol. 2006; 574(Pt 1):7-15. Epub 2006/04/29. https://doi.org/10.1113/jphysiol.2006. 108944 PMID: 16644800; PubMed Central PMCID: PMC1817788.
59. Hardie DG, Hawley SA. AMP-activated protein kinase: the energy charge hypothesis revisited. BioEssays. 2001; 23(12):1112-9. https://doi.org/10.1002/bies.10009 PMID: 11746230
60. Valenzano MC, DiGuilio K, Mercado J, Teter M, To J, Ferraro B, et al. Remodeling of Tight Junctions and Enhancement of Barrier Integrity of the CACO-2 Intestinal Epithelial Cell Layer by Micronutrients. PloS one. 2015; 10(7):e0133926. Epub 2015/08/01. https://doi.org/10.1371/journal.pone.0133926 PMID: 26226276; PubMed Central PMCID: PMCPMC4520484.
61. Song ZH, Ke YL, Xiao K, Jiao LF, Hong QH, Hu CH. Diosmectite-zinc oxide composite improves intestinal barrier restoration and modulates TGF-beta1, ERK1/2, and Akt in piglets after acetic acid challenge. Journal of animal science. 2015; 93(4):1599-607. Epub 2015/05/29. https://doi.org/10.2527/jas.2014-8580 PMID: 26020182.